Page 18 - Recursion Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Finding an up-and-coming stock worth investing in is harder than it used to be, but you don't have to look far if you check out this list.

Recursion Pharmaceuticals (RXRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Baillie Gifford & Co. lowered its holdings in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 2.2% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 24,551,409 shares of the company’s stock after selling 546,221 shares during the quarter. Baillie Gifford & […]

Baillie Gifford & Co. lowered its stake in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 2.2% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 24,551,409 shares of the company’s stock after selling 546,221 shares during the period. Baillie Gifford & Co. owned approximately 11.39% […]

Wall Street's favorite chip maker disclosed stakes in a handful of AI and other companies this week — and promptly sent shares rising